Blood group incompatibility in kidney transplantation: definitely time to re-examine!
Med J Aust
; 187(5): 306-8, 2007 Sep 03.
Article
en En
| MEDLINE
| ID: mdl-17767439
ABSTRACT
We report a successful kidney transplant (A1 donor to an O recipient), with antibody removal pre- and post-transplant, and pre-transplant administration of anti-CD20 monoclonal antibody (rituximab), intravenous immunoglobulin, and conventional transplant immunosuppression. The transplant, which was performed without splenectomy, is the first such transplant in Australia. At 20 months, the patient's creatinine level was 110-130 micromol/L, with no evidence of rejection and no complications. ABO-incompatible transplantation should increase "live donor" kidney transplantation, reduce waiting times, and improve patient outcomes.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Incompatibilidad de Grupos Sanguíneos
/
Trasplante de Riñón
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Med J Aust
Año:
2007
Tipo del documento:
Article
País de afiliación:
Australia